CA2107460A1 - Compositions pharmaceutiques dipeptidiques et methodes d'utilisation - Google Patents

Compositions pharmaceutiques dipeptidiques et methodes d'utilisation

Info

Publication number
CA2107460A1
CA2107460A1 CA002107460A CA2107460A CA2107460A1 CA 2107460 A1 CA2107460 A1 CA 2107460A1 CA 002107460 A CA002107460 A CA 002107460A CA 2107460 A CA2107460 A CA 2107460A CA 2107460 A1 CA2107460 A1 CA 2107460A1
Authority
CA
Canada
Prior art keywords
treatment
subject
trp
glu
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002107460A
Other languages
English (en)
Inventor
Vladimir K. Khavinson
Vyacheslav G. Morozov
German M. Yakovlev
Sergey V. Sery
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CYTRAN Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2107460A1 publication Critical patent/CA2107460A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002107460A 1991-04-01 1992-04-01 Compositions pharmaceutiques dipeptidiques et methodes d'utilisation Abandoned CA2107460A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67812991A 1991-04-01 1991-04-01
US07/678,129 1991-04-01

Publications (1)

Publication Number Publication Date
CA2107460A1 true CA2107460A1 (fr) 1992-10-02

Family

ID=24721510

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002107460A Abandoned CA2107460A1 (fr) 1991-04-01 1992-04-01 Compositions pharmaceutiques dipeptidiques et methodes d'utilisation

Country Status (3)

Country Link
AU (1) AU668088B2 (fr)
CA (1) CA2107460A1 (fr)
WO (1) WO1992017191A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807830A (en) * 1987-12-30 1998-09-15 Cytoven J.V. Method for treatment of purulent inflammatory diseases
US5728680A (en) 1987-12-30 1998-03-17 Cytoven J.V. Methods for normalizing numbers of lymphocytes
US5811399A (en) * 1988-12-14 1998-09-22 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: immunodepressants
US5770576A (en) * 1989-08-30 1998-06-23 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: systemic toxicity
US5902790A (en) * 1995-10-03 1999-05-11 Cytran, Inc. Pharmaceutical angiostatic dipeptide compositions and method of use thereof
DE69230500D1 (de) * 1991-10-28 2000-02-03 Cytran Ltd Pharmazeutische Dipeptid Zusammensetzungen und Verwendungsmethoden.
AU6359594A (en) * 1993-03-04 1994-09-26 Cytoven International N.V. Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof
WO1995003067A1 (fr) * 1993-07-21 1995-02-02 Khavinson Vladimir Khatskelevi Agents pharmaceutiques a activite immunomodulatrice
US5744452A (en) * 1995-11-28 1998-04-28 Edward T. Wei γ-L-glutamyl containing immunomodulator compounds and methods therewith
US5916878A (en) * 1995-11-28 1999-06-29 Edward T. Wei γ-glutamyl and β-aspartyl containing immunomodulator compounds and methods therewith
US6060452A (en) * 1996-03-13 2000-05-09 Cytran, Inc. Analogs of L-Glu-L-Trp having pharmacological activity
KR100464787B1 (ko) * 2002-03-20 2005-01-06 박용석 글루탐산염을 이용한 양전하 지질의 제조방법
KR20090119897A (ko) 2007-02-13 2009-11-20 사이클론 파아머슈티컬 인코오퍼레이티드 점막의 질환으로 인한 조직 악화, 상처 또는 손상을 치료 또는 예방하는 방법
ES2444299B1 (es) 2012-08-23 2014-12-12 Nutrición Técnica Deportiva, S.L. Uso de un hidrolizado de caseina como agente antiherpético
ES2544153B1 (es) 2014-02-24 2016-06-06 Ntd Labs, S.L. Uso de un hidrolizado de caseína como agente antiviral

Also Published As

Publication number Publication date
AU1750392A (en) 1992-11-02
AU668088B2 (en) 1996-04-26
WO1992017191A1 (fr) 1992-10-15

Similar Documents

Publication Publication Date Title
EP0614369B1 (fr) Compositions pharmaceutiques dipeptidiques et leurs procedes d'utilisation
US6139862A (en) Pharmaceutical dipeptide compositions and methods of use thereof
CA2107460A1 (fr) Compositions pharmaceutiques dipeptidiques et methodes d'utilisation
AU712808B2 (en) Drug delivery enhancement via modified saponins
WO2017155234A1 (fr) Peptide pour la prévention ou le traitement de maladies inflammatoires et utilisation associée
WO2017155233A1 (fr) Peptide de prévention ou de traitement de maladies inflammatoires et son utilisation
JPH02502826A (ja) 免疫欠損状態の治療のための医薬製剤
EP0768888A1 (fr) Utilisation de composes peptidiques de muramyle
EP0348086A2 (fr) Peptides, leur emploi comme immuno-suppressifs et procédés pour leur préparation
US6726913B1 (en) Treatment of dermal tumors, warts, and viral infections of the respiratory tract in humans using heat-killed P. acnes
US4039656A (en) Production of attenuated viruses
WO1993008816A1 (fr) Compositions polypetidiques pharmaceutiques contenant de la lysine et procedes d'utilisation desdites compositions
US4049794A (en) Treatment of infections in animals
US20030198617A1 (en) Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof
JPS6225679B2 (fr)
RU2120298C1 (ru) Иммуностимулятор и препарат на его основе
JP2000186040A (ja) 抗ｈｉｖ感染症剤
CN115998761B (zh) 一种抗过敏鼻炎组合物及其制备方法和应用
EP0621789B1 (fr) Compositions pentapeptidiques pharmaceutiques et leurs procedes d'utilisation
JPH05132428A (ja) 点鼻用歯周病予防ワクチン
JP6871760B2 (ja) 抗ウイルス作用促進用組成物
US5334583A (en) Use of sugar derivatives for the prophylaxis and treatment of virus infections
CN114903973A (zh) 一种呼吸道粘膜免疫增强药物组合物
Georgiev Immunotherapy of Infectious Diseases
JP2004182655A (ja) 医薬品組成物

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead